Currently the Enterprise Value (EV) is not available for Sangamo Therapeutics.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 1.13,
with a Debt / Equity ratio of 1.34.
1.13
1.13
1.34
-0.34
-0.45
0
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$315.85K
$-535.2K
183
0.57
n/a
Taxes
-167K
0.17%
Stock Price Statistics
The stock price has increased by -23.93% in the
last 52 weeks. The beta is 1.21, so Sangamo Therapeutics's
price volatility has been higher than the market average.
1.21
-23.93%
0.53
0.96
51.85
5,931,396
Income Statement
In the last 12 months, Sangamo Therapeutics had revenue of 57.8M
and earned -97.94M
in profits. Earnings per share was -0.49.